Curriculum Vitae - Kerrin Leon White, M.D.

Education and Training

• 1963-1965 Phillips Exeter Academy, Exeter, NH: Completion of secondary school education - Awards in English and Latin
• 1965-1969 Harvard College, Cambridge, MA: Completion of BA (Psychology)
  Magna cum Laude with Highest Honors - Phi Beta Kappa - Honors Thesis Research: "Operant Control of EEG Alpha Rhythm" - Course on programming with Fortran
• 1969-1973 Mt. Sinai School of Medicine, New York, NY: Completion of M.D. (1973) - M. Ralph Kaufman Award for Excellence in Psychiatry
• 1973-1976 Los Angeles County-University of Southern California Medical Center, Los Angeles, CA: Internship and Residency in psychiatry
• 1976-1977 LAC-USC: Fellowship in Clinical Psychopharmacology Research
• 1978 Board Certified in Psychiatry
• 1994 Stanford Sleep School of Sleep Medicine, Palo Alto, CA: Week-long Course in Sleep Medicine for Physicians
• 1998 Stanford Medical School:
  Week-long Course in Medical Informatics
• 1986-present Community College of Rhode Island, Warwick, RI:
  Certificate Program in Computers - Courses on Intro to PCs, Windows, Word, E-mail, Web Site Design (FrontPage)
• 1986-present Rhode Island School of Design, Providence, RI: Certificate Program in Computer Graphics - Courses on Introduction to Macs, Adobe Photoshop, Web Site Design (BBEdit)

Academic Positions

• University of Southern California School of Medicine
  • 1976-1977 Clinical Instructor in Psychiatry
  • 1977-1982 Assistant Professor in Psychiatry
  • 1982-1983 Associate Professor in Psychiatry with Tenure
• Harvard Medical School
  • 1983-1984 Instructor in Psychiatry
  • 1984-1990 Assistant Professor in Psychiatry
• Brown Medical School
  • 1991-1994 Associate Professor in Psychiatry

Professional Experience

• 1976-1978 Los Angeles County-University of Southern California Medical Center, Los Angeles, CA
  • Assistant Ward Chief
• 1978-1981 LAC-USCWard Chief
  • Medical Director of Mood Disorders Clinic
  • Director of Depression Clinic
• 1981-1983 LAC-USC:
  • Chief of Psychiatry Consultation-Liaison Service
• 1985-1987 Glendale Adventist Medical Center, Glendale, CA:
  • Attending Physician
• 1983-1987 McLean Hospital, Belmont, MA:
  • Physician in Charge, Clinical Research Unit
• 1984-1987 Metropolitan State Hospital, Waltham, MA:
  • Psychopharmacology Consultant
• 1984-1988 Waltham Hospital, Waltham, MA
  • Attending Physician
• 1987-1990 McLean Hospital:
  • Director of Obsessive Compulsive Disorder Program
• 1990 McLean Hospital:
  • Chief of Outpatient Psychopharmacology
• 1990-1991 Rhode Island Hospital, Providence, RI:
  • Chief of Psychiatric Consultation Service
• 1991-1994 Providence VA Medical Center, Providence, RI:
  • Chief of Psychopharmacology Research
• 1994-1996 St. Elizabeth's Medical Center, Boston, MA:
  • Director of Psychiatric Consultation-Liaison Service
  • Clinical Director of Psychiatry
  • Director of Medical Student Education
  • Association for the Advancement of Behavior Therapy
  • American Psychiatric Society
  • Society for Biological Psychiatry
  • Collegium Internationale Neuro-Psychopharmacologicum
  • American Psychosomatics Association
  • Society for Clinical Psychopharmacology Research
  • American Sleep Disorders Association
  • Narcolepsy Association
  • A.W.A.K.E.
  • American Medical Informatics Association

Internet Experience

• TalkAboutSleep.com:
  • Chat facilitator for online sleep apnea chat (See our Chat Calendar)
  • Contributor and Expert Consultant for Ask The eXperts
• America On Line:
  • Leader for on-line Depression and Sleep Disorders Chat Groups
  • Monitor for substance abuse bulletin board
• AllExperts.com:
  • Expert consultant on sleep apnea and psychiatry
• BriefMe.com:
  • Editor reviewing medicine and health related websites
• Suite101.com:
  • Article writer on medical practice

Awards

• 1973 M. Ralph Kaufman Award in Psychiatry, Mt Sinai School of Medicine
• 1979 Junior Faculty Award in Research, LAC-USC Medical Center
• 1994 Exemplary Psychiatrist Award, National Alliance for the Mentally Ill

Publications

1. White, K. Encounters at Esalen, S. Cal. Psychiatric Assn. Newsletter, 1975
2. White, K. Tricyclic overdosage in a patient given combined tricyclic-MAOI treatment, American Journal of Psychiatry, 135:1411-1412, 1978
3. White, K., Bohart, R., Whipple, K., and Boyd, J. Lithium effects on normal subjects: relationship to plasma and RBC lithium levels, International Pharmacopsychiatry, 14:176-183, 1979
4. White, K., Cohen, J., Boyd, J., Nelson, R. Relationship between plasma, RBC, and CSF lithium concentrations in human subjects, International Pharmacopsychiatry, 14:663-669, 1979
5. White, K., Bohart, R., and Eaton, E. RBC lithium uptake ratios in manics, schizophrenics, and normals, Biological Psychiatry, 14:663-669, 1979
6. Eaton, E.M., Busk, J., Maloney, M.P., Sloane, R.B., Whipple, K., and White, K. Hemispheric dysfunction in schizophrenia: Assessment by visual perception tasks, Psychiatry Research, 1:325-332, 1979
7. White, K. and Sloane, R.B. Drugs in Brief Psychotherapy, Psychiatric Clinics of North America, 2:171-187, 1979
8. White, K. Advisability of combined treatment (letter), American Journal of Psychiatry, 135:729, 1979
9. White, K., Pistole, T., Boyd, J.L. Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study, American Journal of Psychiatry, 137:1422-1425, 1980
10. White, K., Shih, J., Fong, T.L., Young, H., Gelfand, R., Boyd, J., Simpson, G., and Sloane, R.B. Elevated platelet monoamine oxidase activity in patients with nonendogenous depression, American Journal of Psychiatry, 137:1258-1259, 1980
11. White, K., Cohen, L.J., and Deandrea, D. An unusual movement disorder associated with neuroleptic treatment: tardive dyskinesia? The Journal of Nervous and Mental Disorders, 168:442-444
12. White, K. and Simpson, G. Combined MAOI-tricyclic antidepressant treatment: a reevaluation, Journal of Clinical Psychopharmacology, 1:264-279, 1981
13. White, K., Busk, J., Eaton, E., Gomez, G., Razani, J., and Sloane, R.B. Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics, International Pharmacopsychiatry, 16:34-38, 1981
14. Simpson, G.M., White, K.L., Boyd, J.L., Cooper, T.B., Halaris, A., Wilson, I.C., Raman, E.J., and Ruther, E. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine, American Journal of Psychiatry, 139:358-360, 1982
15. Simpson, G. and White, K. Monoamine oxidase inhibitors: their use in clinical practice. Hospital and Community Psychiatry, 33:615-616, 1982
16. White, K., O'Leary, J., Razani, J., Rebal, R., and Palmer, R. Electrocardiographic effects of tranylcypromine vs. amitriptyline. Journal of Clinical Psychiatry, 44:91-92, 1983
17. Simpson, G., White, K., Pi, E., Razani, J., and Sloane, R.B. Monoamine oxidase inhibition and tyramine sensitivity in L-deprenyl treated subjects. Psychopharmacology Bulletin, 11119:340-342, 1983
18. Slonim, D. and White, K. Homeopathy and psychiatry. The Journal of Mind and Behavior, 4:401-410, 1983
19. Razani, R., White, K.L., White, J., Simpson, G., Sloane, R.B., Rebal, R., and Palmer, R. Amitriptyline and tranylcypromine antidepressant treatment: a controlled trial. Archives of General Psychiatry, 40:657-661, 1983
20. White, K. and Simpson, G. The combined use of MAOIs and tricyclics. Journal of Clinical Psychiatry, 45:67-69, 1984
21. Zimmerli, M. and White, K. The use of the dexamethasone suppression test to diagnose Briquet's syndrome (somatization disorder): report of a case. Journal of the American Osteopathic Association, 83:502-504, 1984
22. Baron, D.A., Shea, S., and White, K. The dexamethasone suppression test: some limitation in the general hospital setting. Journal of the American Osteopathic Association, 83:503-508, 1984
23. White, J., White, K., and Razani, J. Effects of endogenicity and severity on consistency of standard depression rating scales. Journal of Clinical Psychiatry, 45:260-261, 1984
24. White, K., Razani, J., Cadow, B., Gelfand, R., Palmer, R., Simpson, G., and Sloane, R.B. Tranylcypromine vs. nortriptyline vs. placebo in depressed outpatients: a controlled trial. Psychopharmacology, 82:258-262, 1984
25. White, K. and Simpson, G. The combined use of MAOIs and tricyclics. Journal of Clinical Psychiatry, 45:67-69, 1984
26. White, K. and Simpson, G. Should the use of MAO inhibitors be abandoned? Integrative Psychiatry, 3:34-45, 1985
27. Simpson, G.M., Frederickson, E., Palmer, R., Pi, E., Sloane, R.B., and White, K. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use. Biological Psychiatry, 20:684-687, 1985
28. White, K., Keck, P.E., and Lipinski, J. Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report. Comprehensive Psychiatry, 27:211-214, 1986
29. Keck, P.E., Lipinski, J.F., and White, K. An inverse relationship between mania and obsessive-compulsive disorder: a case report (letter). Journal of Clinical Psychopharmacology, 6:123-124, 1986
30. Dilsaver, S.C. and White, K. Affective disorders and associated psychopathology: a family history study. Journal of Clinical Psychiatry, 47:162-169, 1986
31. White, K. and White, J. Tranylcypromine: patterns and predictors of response. Journal of Clinical Psychiatry, 47:380-382, 1986
32. Simpson, G.M. and White, K. Management of MAOI overdose including hypertensive crisis. In: Current Concepts in MAOI Therapy, New York:Audio-Visual Medical Marketing, 1987
33. White, K. and Simpson, G. Treatment-resistant depression. Psychiatric Annals, 17:274-278, 1987
34. Keck, P.E., Vuckovic, A., Pope, H.G., Nierenberg, A.A., Gribble, G.W. and White, K. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment. Journal of Clinical Psychopharmacology Research, 9:203-206, 1989
35. Bodkin, J.A. and White, K. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient. Journal of Clinical Psychiatry, 50:265-266, 1989
36. Chouinard, G., Goodman, W., Greist, J., Jenike, M., Rasmussen, S., White, K., Hackett, E., Gaffney, M., and Bick, P.A. Results of a double-blind placebo controlled study of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacology Bulletin, 26:279-284, 1990
37. White, K., Wykoff, W., Tynes, L.L., Schneider, L., and Zemansky, M. Fluvoxamine in the treatment of tricyclic-resistant depression. Psychiatric Journal of the University of Ottawa, 15:156-158, 1990
38. Tynes, L.L., White, K., and Steketee, G.B. Toward a new nosology of obsessive compulsive disorder. Comprehensive Psychiatry, 31:465-480, 1990
39. White, K. and Cole, J. Pharmacotherapy of OCD in: Bellack, S. and Hersen, M. (Eds.), Handbook of Comparative Treatments for Adult Disorders, New York: Wiley, 1990
40. Nierenberg, A.A. and White, K. What next? A review of pharmacologic strategies for treatment resistant depression. Psychopharmacology Bulletin, 26:429-460, 1990
41. Steketee, G. and White, K. When Once Is Not Enough: Help for Obsessive-Compulsives. Oakland: New Harbinger Publications, 1990
42. Steketee, G., Quay, S., and White, K. Religion and guilt in OCD patients. Journal of Anxiety Disorders, 5:359-367, 1991
43. White, K. and Shields, J. Conversion of inpatient mental health benefits to outpatient benefits. Hospital and Community Psychiatry, 42:570-572
44. Yonkers, K. and White, K. Premenstrual exacerbation of depression: one process or two? Journal of Clinical Psychiatry, 53:289-292, 1992
45. Yonkers, K.A., Ellison, J.M., Shera, D.M., Pratt, L.A., Langford, L.M., Cole, J.O., White, K., Lavori, P.W., and Keller, M.B. Pharmacotherapy observed in a large prospective longitudinal study on anxiety disorders. Psychopharmacology Bulletin, 28:131-137, 1992
46. White, K., Kando, J., Park, T., Waternaux, C., and Brown, W.A. Side effects and the "blindability" of clinical drug trials. American Journal of Psychiatry, 149:1730-1731, 1992
47. White, K. Anxiety disorders: an overview. Rhode Island Medicine,
48. Mallya, G.K., White, K., Waternaux, C., and Quay, S. Short- and long-term treatment of obsessive-compulsive disorder with fluvoxamine. Annals of Clinical Psychiatry, 4:77-80, 1992
49. White, J., Davison, G.C., Haaga, D.A. and White, K. Cognitive bias in the articulated thoughts of depressed and nondepressed psychiatric patients. Journal of Nervous and Mental Disease, 180:77-81, 1992
50. Mallya, G., White, K. and Gunderson, J. Is there a serotonergic withdrawal syndrome? (letter). Biological Psychiatry, 33:851-852, 1993
51. Reich, J., Warshaw, M., Peterson, L.G., White, K., Keller, M., Lavori, P., and Yonkers, K.A. Comorbidity of panic and major depressive disorder. Journal of Psychiatric Research, 27S:23-33, 1993
52. Vincent, M. and White, K. Patient violence toward a nurse: predictable and preventable? Journal of Psychosocial Nursing, 32:30-32, 1994
53. Rogers, M.P., White, K., Warshaw, M.G., Yonkers, K.A., Rodriguez-Villa, F., Chane, G., and Keller, M.B. Prevalence of medical illness in patients with anxiety disorders. International Journal of Psychiatry in Medicine, 24:83-96, 1994
54. Oxenkrug, G.F., Requintina, P.J., McIntyre, I.M., and White, K. Chronopharmacologic study of moclobemide effects on the rat pineal melatonin biosynthesis. Journal of Neural Transmission, 41S:335-337, 1994
55. Oxenkrug, G.F., Requintina, P.J., McIntyre, I.M., and White, K. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis. Journal of Neural Transmission, 41S:381-384, 1994
56. Greist, J., Chouinard, E., DuBoff, E., Halaris, A., Kim, S.W., Koran, K., Liebowitz, M., Lydiard, R.B., Rasmussen, S., White, K., et al. Double-blind parallel comparisons of three doses of sertraline and placebo in outpatients with obsessive-compulsive disorder, Archives of General Psychiatry, 52:289-295, 1995
57. Goldenberg, I.M., White, K., Yonkers, K., Reich, J., Warshaw, M.G., Goisman, R.M., and Keller, M.B. The infrequency of "pure culture" diagnosis among the anxiety disorders. Journal of Clinical Psychiatry, 57:528-533, 1996
58. Goodman, W.K., Kozak, M.J., Liebowitz, M., and White, K. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. International Clinical Psychopharmacology, 11:21-29, 1996